First Trust Health Care AlphaDEX Fund
$ 115.45
-0.42 %
The First Trust Health Care AlphaDEX Fund, an exchange-traded fund (ETF), aims to deliver investment performance that broadly matches the total return (price appreciation and income generation) of the StrataQuant Health Care Index, an equity benchmark. This goal is measured prior to the subtraction of any fees and expenses.
Volume: $44.206 K
Overview
Loading data...
FXH vs S&P500
Loading data...
No data available.
Inside First Trust Health Care AlphaDEX Fund
| Symbol | Name | Share number | Weight | Value |
|---|---|---|---|---|
| HUM | Humana Inc. | 107020 | 4.469 % | 40.272 M $ |
| OGN | Organon & Co. | 2478297 | 3.854 % | 34.728 M $ |
| DVA | DaVita Inc. | 120739 | 2.906 % | 26.192 M $ |
| ELV | Elevance Health Inc. | 63386 | 2.851 % | 25.694 M $ |
| EXEL | Exelixis, Inc. | 432648 | 2.6 % | 23.433 M $ |
| MOH | Molina Healthcare, Inc. | 111365 | 2.519 % | 22.702 M $ |
| SOLV | Solventum Corporation | 284168 | 2.482 % | 22.365 M $ |
| BIIB | Biogen Inc. | 101218 | 2.304 % | 20.761 M $ |
| CAH | Cardinal Health, Inc. | 87815 | 2.255 % | 20.319 M $ |
| CI | The Cigna Group | 69564 | 2.249 % | 20.270 M $ |
| INCY | Incyte Corporation | 197156 | 2.242 % | 20.205 M $ |
| BIO | Bio-Rad Laboratories, Inc. (Class A) | 66569 | 2.177 % | 19.617 M $ |
| ZBH | Zimmer Biomet Holdings, Inc. | 205223 | 2.09 % | 18.837 M $ |
| CHE | Chemed Corporation | 39299 | 1.985 % | 17.889 M $ |
| GMED | Globus Medical, Inc. (Class A) | 215370 | 1.976 % | 17.804 M $ |
| EHC | Encompass Health Corporation | 153468 | 1.742 % | 15.697 M $ |
| HCA | HCA Healthcare, Inc. | 39211 | 1.703 % | 15.349 M $ |
| IONS | Ionis Pharmaceuticals, Inc. | 197695 | 1.697 % | 15.289 M $ |
| REGN | Regeneron Pharmaceuticals, Inc. | 24017 | 1.696 % | 15.285 M $ |
| UHS | Universal Health Services, Inc. (Class B) | 103684 | 1.695 % | 15.272 M $ |
| ILMN | Illumina, Inc. | 90328 | 1.693 % | 15.261 M $ |
| PEN | Penumbra, Inc. | 45209 | 1.66 % | 14.962 M $ |
| AMGN | Amgen Inc. | 42191 | 1.649 % | 14.861 M $ |
| MRK | Merck & Co., Inc. | 123410 | 1.627 % | 14.662 M $ |
| QGEN | QIAGEN N.V. | 370755 | 1.586 % | 14.294 M $ |
| BDX | Becton, Dickinson and Company | 94416 | 1.574 % | 14.183 M $ |
| THC | Tenet Healthcare Corporation | 78665 | 1.572 % | 14.164 M $ |
| UTHR | United Therapeutics Corporation | 25034 | 1.555 % | 14.015 M $ |
| PFE | Pfizer Inc. | 528669 | 1.543 % | 13.906 M $ |
| NTRA | Natera, Inc. | 55672 | 1.492 % | 13.442 M $ |
| RVTY | Revvity, Inc. | 127083 | 1.471 % | 13.260 M $ |
| HSIC | Henry Schein, Inc. | 151068 | 1.398 % | 12.597 M $ |
| DGX | Quest Diagnostics Incorporated | 56810 | 1.283 % | 11.559 M $ |
| UNH | UnitedHealth Group Incorporated | 27432 | 1.273 % | 11.475 M $ |
| CERT | Certara, Inc. | 1953289 | 1.253 % | 11.291 M $ |
| LH | Labcorp Holdings Inc. | 41728 | 1.236 % | 11.138 M $ |
| COO | The Cooper Companies, Inc. | 155718 | 1.188 % | 10.708 M $ |
| STE | Steris Plc | 50350 | 1.181 % | 10.644 M $ |
| MDT | Medtronic Plc | 128492 | 1.18 % | 10.637 M $ |
| BMY | Bristol-Myers Squibb Company | 183573 | 1.148 % | 10.343 M $ |
| GILD | Gilead Sciences, Inc. | 79886 | 1.145 % | 10.316 M $ |
| GEHC | GE HealthCare Technologies Inc. | 156417 | 1.115 % | 10.052 M $ |
| RMD | ResMed Inc. | 49599 | 1.083 % | 9.762 M $ |
| SRPT | Sarepta Therapeutics, Inc. | 511662 | 1.038 % | 9.359 M $ |
| NBIX | Neurocrine Biosciences, Inc. | 56341 | 1.033 % | 9.305 M $ |
| WAT | Waters Corporation | 24924 | 1.026 % | 9.244 M $ |
| LLY | Eli Lilly and Company | 8070 | 1.026 % | 9.250 M $ |
| INSM | Insmed Incorporated | 90785 | 1.007 % | 9.074 M $ |
| A | Agilent Technologies, Inc. | 65122 | 0.958 % | 8.633 M $ |
| ALGN | Align Technology, Inc. | 43297 | 0.913 % | 8.226 M $ |
| HALO | Halozyme Therapeutics, Inc. | 114845 | 0.911 % | 8.214 M $ |
| IQV | IQVIA Holdings Inc. | 43524 | 0.845 % | 7.619 M $ |
| BMRN | BioMarin Pharmaceutical Inc. | 131396 | 0.832 % | 7.498 M $ |
| MEDP | Medpace Holdings, Inc. | 15457 | 0.823 % | 7.421 M $ |
| TMO | Thermo Fisher Scientific Inc. | 15101 | 0.812 % | 7.320 M $ |
| JNJ | Johnson & Johnson | 30365 | 0.803 % | 7.236 M $ |
| ABT | Abbott Laboratories | 72294 | 0.74 % | 6.669 M $ |
| MDLN | Medline Inc. (Class A) | 166798 | 0.694 % | 6.255 M $ |
| ZTS | Zoetis Inc. | 62791 | 0.572 % | 5.157 M $ |
| WST | West Pharmaceutical Services, Inc. | 13882 | 0.527 % | 4.750 M $ |
| DXCM | DexCom, Inc. | 55404 | 0.465 % | 4.189 M $ |
| RPRX | Royalty Pharma Plc (Class A) | 72531 | 0.445 % | 4.008 M $ |
| SHC | Sotera Health Company | 242630 | 0.444 % | 4.005 M $ |
| EW | Edwards Lifesciences Corporation | 43447 | 0.439 % | 3.960 M $ |
| NVST | Envista Holdings Corporation | 137143 | 0.411 % | 3.707 M $ |
| VRTX | Vertex Pharmaceuticals Incorporated | 7792 | 0.407 % | 3.671 M $ |
| IDXX | IDEXX Laboratories, Inc. | 6192 | 0.403 % | 3.631 M $ |
| ABBV | AbbVie Inc. | 15998 | 0.401 % | 3.614 M $ |
| SYK | Stryker Corporation | 10588 | 0.377 % | 3.401 M $ |
| VKTX | Viking Therapeutics, Inc. | 106925 | 0.376 % | 3.389 M $ |
| DHR | Danaher Corporation | 18350 | 0.376 % | 3.392 M $ |
| ISRG | Intuitive Surgical, Inc. | 7547 | 0.355 % | 3.203 M $ |
| VEEV | Veeva Systems Inc. (Class A) | 19808 | 0.352 % | 3.168 M $ |
| ALNY | Alnylam Pharmaceuticals, Inc. | 10516 | 0.339 % | 3.051 M $ |
| BSX | Boston Scientific Corporation | 55447 | 0.291 % | 2.620 M $ |
| $USD | US Dollar | 0 | 0.159 % | 1.433 M $ |